JP Morgan Chase’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19K Buy
10,876
+10,400
+2,185% +$18K ﹤0.01% 6562
2025
Q4
$643 Hold
476
﹤0.01% 7064
2025
Q3
$776 Sell
476
-32,472
-99% -$36K ﹤0.01% 7012
2025
Q2
$32K Sell
32,948
-108,710
-77% -$90.2K ﹤0.01% 6060
2025
Q1
$100K Sell
141,658
-154,957
-52% -$107K ﹤0.01% 5567
2024
Q4
$239K Buy
296,615
+177,594
+149% +$163K ﹤0.01% 5401
2024
Q3
$118K Buy
119,021
+9,773
+9% +$13.4K ﹤0.01% 5630
2024
Q2
$169K Sell
109,248
-282,677
-72% -$440K ﹤0.01% 5240
2024
Q1
$643K Buy
391,925
+209,112
+114% +$175K ﹤0.01% 4633
2023
Q4
$105K Buy
182,813
+48,336
+36% +$19.4K ﹤0.01% 5711
2023
Q3
$53.8K Sell
134,477
-2,905,579
-96% -$1.43M ﹤0.01% 5780
2023
Q2
$1.65M Sell
3,040,056
-101,501
-3% -$65.1K ﹤0.01% 3685
2023
Q1
$2.68M Sell
3,141,557
-625,311
-17% -$682K ﹤0.01% 3330
2022
Q4
$4.9M Buy
3,766,868
+634,682
+20% +$989K ﹤0.01% 2832
2022
Q3
$5.58M Sell
3,132,186
-162,082
-5% -$404K ﹤0.01% 2652
2022
Q2
$7.48M Sell
3,294,268
-721,474
-18% -$1.73M ﹤0.01% 2401
2022
Q1
$13.3M Buy
4,015,742
+693,786
+21% +$2.44M ﹤0.01% 2102
2021
Q4
$15.1M Buy
3,321,956
+2,762,832
+494% +$20.9M ﹤0.01% 2073
2021
Q3
$4.01M Buy
559,124
+440,971
+373% +$3.24M ﹤0.01% 3220
2021
Q2
$948K Buy
+118,153
New +$997K ﹤0.01% 4339
2021
Q1
Sell
-21
Closed 6259
2020
Q4
$0 Sell
21
-65,279
-100% -$31.5K ﹤0.01% 5843
2020
Q3
$20K Buy
+65,300
New +$25K ﹤0.01% 5145
2018
Q3
Sell
-204
Closed -$31K 5768
2018
Q2
$31K Sell
204
-1,735
-89% -$270K ﹤0.01% 5225
2018
Q1
$320K Buy
+1,939
New +$309K ﹤0.01% 4195
2015
Q3
Sell
-1,290
Closed -$500K 4025
2015
Q2
$500K Buy
+1,290
New +$621K ﹤0.01% 3556

Other funds holding OCGN

JP Morgan Chase's OCGN Position: Q1 2026 in Review

JP Morgan Chase increased its Ocugen (OCGN) stake by 2,185% in Q1 2026, buying an estimated $18K and bringing the position to 10,876 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #6562.

JP Morgan Chase first reported a position in OCGN in Q2 2015 and has held it in 25 quarters since. The position peaked at $15.1M in Q4 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • JP Morgan Chase held 10,876 shares of Ocugen worth $19K as of Q1 2026.
  • JP Morgan Chase bought 10,400 Ocugen shares in Q1 2026, an estimated $18K.
  • Ocugen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6562 holding.
  • JP Morgan Chase first reported a position in Ocugen in Q2 2015 and has held it in 25 quarters since.
  • JP Morgan Chase's Ocugen position peaked at $15.1M in Q4 2021.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.